Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
secondary literature
Justification for type of information:
Data is from the safety assessment repot.

Data source

Reference
Reference Type:
secondary source
Title:
OPINION ON PHENYLBENZIMIDAZOLE SULFONIC ACID AND ITS SALTS
Author:
HEALTH AND CONSUMER PROTECTION DIRECTORATE GENERAL
Year:
2006
Bibliographic source:
OPINION ON PHENYLBENZIMIDAZOLE SULFONIC ACID AND ITS SALTS- SCCP/1056/06

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Principles of method if other than guideline:
The skin sensitisation study was conducted on guinea pigs to determine its sensitisation potential of 2-phenyl-1H-benzimidazole-5-sulphonic acid.
GLP compliance:
not specified
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
not specified

Test material

Constituent 1
Reference substance name:
Ensulizole
IUPAC Name:
Ensulizole
Constituent 2
Reference substance name:
2-phenyl-1H-benzimidazole-5-sulphonic acid
EC Number:
248-502-0
EC Name:
2-phenyl-1H-benzimidazole-5-sulphonic acid
Cas Number:
27503-81-7
IUPAC Name:
2-phenyl-1H-benzimidazole-5-sulfonic acid
Test material form:
solid
Details on test material:
- IUPAC name:Phenylbenzimidazole Sulfonic Acid
- Molecular formula: C13H10N2O3S
- Molecular weight: 274.299g/mol
- Substance type: organic
-Physical state: solid
Specific details on test material used for the study:
-IUPAC name: 2-phenyl-1H-benzimidazole-5-sulphonic acid
- Name of test material (as cited in study report): HR 92/103089
- Molecular formula: C13H10N2O3S
- Molecular weight: 274.299g/mol
- Substance type: organic
-Physical state: solid

In vivo test system

Test animals

Species:
guinea pig
Strain:
Dunkin-Hartley
Sex:
not specified
Details on test animals and environmental conditions:
No data available.

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal
Vehicle:
water
Concentration / amount:
0.1ml Freund’s complete adjuvant in water
Route:
intradermal
Vehicle:
arachis oil
Concentration / amount:
2-phenyl-1H-benzimidazole-5-sulphonic acid 1% w/v in arachis oil
Day(s)/duration:
Not specified
Adequacy of induction:
not specified
Route:
intradermal
Vehicle:
arachis oil
Concentration / amount:
Freund’s + 2-phenyl-1H-benzimidazole-5-sulphonic acid 1% w/v in arachis oil (1:1)
Day(s)/duration:
Not specified
Adequacy of induction:
not specified
Route:
other: Topical Application
Vehicle:
arachis oil
Concentration / amount:
•0.2 – 0.3 ml HR 92/103089 50% w/w in arachis oil
Day(s)/duration:
48 hours
Challenge
No.:
#1
Route:
other: Epicutaneous
Vehicle:
arachis oil
Concentration / amount:
0.1-0.2 ml 2-phenyl-1H-benzimidazole-5-sulphonic acid and 10% w/w in arachis oil
Day(s)/duration:
21 days
Adequacy of challenge:
not specified
No. of animals per dose:
20 test; 10 negative control
Details on study design:
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 1
- Exposure period: 1 week
- Topical: 48 hours
- Test groups: 20
- Control group: 10
- Site: intradermal : three separate sites.
- Duration: Intradermal-1 week
Topical-48 hours
- Concentrations:
INTRADERMAL
•0.1ml Freund’s complete adjuvant in Water
•HR 92/103089 ((Phenylbenzimidazole Sulfonic Acid ) 1% w/v in arachis oil.
•Freund’s + HR 92/103089 1% w/v in arachis oil (1:1)

TOPICAL
After 1 week, a single topical application of 0.2 – 0.3 ml HR 92/103089 50% w/w in arachis oil under occlusion for 48 hours.

B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: On day 21
- Exposure period: No Data Available
- Test groups: 20
- Control group: 10
- Site: No Data Available
- Concentrations: 0.1-0.2 ml HR 92/103089 25 and 10% w/w in arachis oil.
- Evaluation (hr after challenge): No data available.
Challenge controls:
No Data Available
Positive control substance(s):
not specified

Results and discussion

In vivo (non-LLNA)

Results
Reading:
1st reading
Group:
other: 20 test; 10 negative control
Dose level:
0.1-0.2 ml 2-phenyl-1H-benzimidazole-5-sulphonic acid and 10% w/w in arachis oil
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
No reactions were observed.
Remarks on result:
no indication of skin sensitisation

In vivo (LLNA)

Cellular proliferation data / Observations:
No reactions were observed.

Applicant's summary and conclusion

Interpretation of results:
other: not sensitising
Conclusions:
The substance 2-phenyl-1H-benzimidazole-5-sulphonic acid was observed to be not sensitising to guinea pigs skin.
Executive summary:

The skin sensitisation study was conducted according to OECD guideline 406 on guinea pigs by Magnusson and Kligman test to determine its sensitisation potential of 2-phenyl-1H-benzimidazole-5-sulphonic acid. 20 test group and 10 negative control groups were used in this study. Intradermal injections of 0.1ml Freund’s complete adjuvant in water 2 -phenyl-1H-benzimidazole-5 -sulphonic acid 1% w/v in arachis oil, and Freund’s test material 1% w/v in arachis oil (1:1) into three separate sites. After 1 week, a single topical application of 0.2 – 0.3 ml test material 50% w/w in arachis oil under occlusion for 48 hours. On day 21 animals were challenged with0.1-0.2 ml 2-phenyl-1H-benzimidazole-5-sulphonic acid and 10% w/w in arachis oil. No reactions were observed. Thus, from the study it can be concluded that the substance 2-phenyl-1H-benzimidazole-5-sulphonic acid is not a skin sensitiser.